Literature DB >> 7388250

Sleep disorder over time: psychiatric correlates among males.

H Sweetwood, I Grant, D F Kripke, M S Gerst, J Yager.   

Abstract

This 18 month prospective study assessed the time course of sleep disturbances in 85 male psychiatric out-patients and 103 male non-patients. Over one-third of the patients and 5 per cent of the non-patients reported frequent symptoms of insomnia during at least 14 of the 18 months. Frequency and chronicity of insomnia were strongly associated with intensity of psychiatric symptomatology, but not with diagnosis. Minor tranquillizers and hypnotics were used frequently by patients and occasionally by non-patients, but there was little indication that they altered the course of insomnia.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7388250     DOI: 10.1192/bjp.136.5.456

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  5 in total

1.  Sleepiness Versus Sleeplessness: Shift Work and Sleep Disorders in the Primary Care Setting.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

Review 2.  Impact of insomnia on health-related quality of life.

Authors:  C Idzikowski
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

3.  Temporally related changes of sleep complaints in traumatic brain injured patients.

Authors:  M Cohen; A Oksenberg; D Snir; M J Stern; Z Groswasser
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-04       Impact factor: 10.154

4.  Actigraphic estimates of circadian rhythms and sleep/wake in older schizophrenia patients.

Authors:  J Martin; D V Jeste; M P Caliguiri; T Patterson; R Heaton; S Ancoli-Israel
Journal:  Schizophr Res       Date:  2001-01-15       Impact factor: 4.939

Review 5.  New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon.

Authors:  Mario Giovanni Terzano; Mariano Rossi; Vincenzo Palomba; Arianna Smerieri; Liborio Parrino
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.